---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-21-014614"
form_type: "8-K"
ticker: "PGNY"
cik: "0001551306"
company_name: "Progyny, Inc."
filed_at: "2021-11-04T23:59:59+00:00"
generated_at: "2026-06-28T12:56:49.551192+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.95
calibrated_materiality_score: 0.95
confidence: "high"
source: SEC EDGAR
---

# Progyny Reports Q3 2021 Revenue of $122.3M, Appoints Pete Anevski as CEO

## Summary
- Q3 2021 revenue $122.3M (+24% YoY), net income $16.8M vs $4.8M in prior year.
- Added 85+ new clients for 2022, representing approximately 1.2M new covered lives.
- David Schlanger to become Executive Chairman; Pete Anevski succeeds as CEO effective Jan 1, 2022.
- Full-year 2021 revenue guidance raised to $507M-$514M, growth of 47-49%.

## SEC filing metadata
- accession: 0001558370-21-014614
- form_type: 8-K
- ticker: PGNY
- cik: 0001551306
- company_name: Progyny, Inc.
- filed_at: 2021-11-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.95
- calibrated_materiality_score: 0.95
- confidence: high
- sec_items: 2.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1551306/000155837021014614/0001558370-21-014614-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1551306/000155837021014614/pgny-20211104x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-21-014614
- JSON: https://secwatch.observer/filing/0001558370-21-014614.json
- Plain text: https://secwatch.observer/filing/0001558370-21-014614.txt

## Key facts
- Executive change
  David Schlanger changed role as Executive Chairman at Progyny, Inc..
  - Action: transition to
  - Role: Executive Chairman
  source text: On November 4, 2021, Progyny, Inc. (the “Company”) announced that David Schlanger plans to transition to the role of Executive Chairman, effective as of January 1, 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1551306/000155837021014614/0001558370-21-014614-index.htm
- Executive change
  Beth Seidenberg was appointed as Lead Independent Director at Progyny, Inc..
  - Action: assume
  - Role: Lead Independent Director
  source text: Beth Seidenberg, M.D., who currently serves as Chair of the Board, will assume the position of Lead Independent Director.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1551306/000155837021014614/0001558370-21-014614-index.htm
- Executive change
  Pete Anevski was appointed as Director at Progyny, Inc..
  - Action: appointed
  - Role: Director
  source text: the Board has appointed Mr. Anevski as a director of the Company effective as of the date he becomes Chief Executive Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1551306/000155837021014614/0001558370-21-014614-index.htm
- Executive change
  Michael Sturmer changed role as President at Progyny, Inc..
  - Action: succeed
  - Role: President
  source text: Michael Sturmer, 45, who currently serves as Executive Vice President, Chief Growth and Strategy Officer, will succeed Mr. Anevski as President, effective as of January 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1551306/000155837021014614/0001558370-21-014614-index.htm
- Executive change
  Pete Anevski changed role as Chief Executive Officer at Progyny, Inc..
  - Action: succeed
  - Role: Chief Executive Officer
  source text: Pete Anevski, 54, who currently serves as President and Chief Operating Officer, will succeed Mr. Schlanger as Chief Executive Officer, effective as of January 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1551306/000155837021014614/0001558370-21-014614-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.